In a stunning decision, Codexis is not going
to develop franchise of CodeXol detergent alcohols along with that of its
CodeXyme cellulose enzymes business for the present year. The company has
announced it right at the call of third quarter earnings and the sole reason
has been attributed to unsecured partnership for the business of cellulose
enzymes. Cellulose is converted into fermentable glucose with the help of
cellulose enzyme’s catalyzing effect which is further used in the production of
CodeXol. This decision can be viewed in the context of battle between Codexis
and Dyadic, enzyme producer which witnessed license agreement breach related to
proprietary fungal expression technique of enzyme production. It is rather not
interested in losing cash fees and thus; Codexis has decided to quit the
business.
However, Codexis has focused completely on the
biocatalysis business in order to supply and develop more enzymes so that
chemical and pharmaceutical manufacturers can enjoy cost reduction along with
efficiency. By the end of year, the company is ought to reduce its operations
costs. Recently appointed Vice President, Greg Hughes has worked at Merck in
Process Chemistry for the last 11 years so that more research works can be
outsourced in biocatalysis technology. On the other hand, LS9 which is known
for its work on fatty alcohols and along with its newly hired CEO, Tjerk de
Ruiter is hoping for some partnership in the commercial production of fatty
alcohols which is completely sugar-based.
Hiç yorum yok:
Yorum Gönder